Apr 19, 2023 / 02:15PM GMT
Joey Stringer - Needham & Company - Moderator
Good morning, everyone. Thank you for joining the 22nd Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Lexicon Pharmaceuticals. Joining us today from the company is CEO, Lonnel Coats; CFO, Jeff Wade; and CMO, Craig Granowitz.
For those of you joining on the webcast, if you want to ask a question, you can do so by using the chat box feature at the bottom of your screen. So with that, we'll go ahead and get started.
Lonnel, Jeff, and Craig, thank you so much for joining us today.
Lonnel Coats - Lexicon Pharmaceuticals, Inc. - CEO and Director
Thanks, Joey.
Questions and Answers:
Joey Stringer - Needham & Company - ModeratorSo we'll get right into it with sotagliflozin. You have an upcoming US approval decision here next month. Any new updates you can provide us on that?
Lonnel Coats<